Diagnosis and Management of Cognitive Impairment in Parkinson's Disease

Alanna Dancis, Valerie T. Cotter

Research output: Contribution to journalArticlepeer-review

3 Scopus citations


Originally considered a movement disorder that did not affect cognition, it is now understood that cognitive impairment is widespread among those with Parkinson's disease. Patients present with a variety of cognitive deficits, including executive dysfunction, visuospatial impairment, and memory loss. Neuropsychiatric symptoms are common, particularly psychosis, depression, and anxiety. Rivastigmine and donepezil have both been shown in large, blinded studies to slow the progression of dementia, although rivastigmine is the only medication approved by the United States Food and Drug Administration. Cognitive rehabilitation may be a safe alternative if medications are intolerable. Research is still needed at all levels to gain understanding of this disease process.

Original languageEnglish (US)
Pages (from-to)307-313
Number of pages7
JournalJournal for Nurse Practitioners
Issue number3
StatePublished - 2015
Externally publishedYes


  • Cognitive impairment
  • Dementia
  • Geriatrics
  • Movement disorder
  • Parkinson's disease

ASJC Scopus subject areas

  • Advanced and Specialized Nursing


Dive into the research topics of 'Diagnosis and Management of Cognitive Impairment in Parkinson's Disease'. Together they form a unique fingerprint.

Cite this